Patient-centered care is easy to talk about but challenging to deliver. It demands a team of experienced physicians and a culture of interdisciplinary collaboration that fosters the most informed decisions possible for each patient.
Optimizing outcomes for advanced heart failure patients depends on a collaborative approach that considers both physical and psychosocial factors and a full array of potential therapies, including the new HeartWare pump for mechanical circulatory support.
New techniques make ablation an increasingly attractive option for ventricular tachycardia (VT) because it can reduce the risks and side effects associated with medications, completely cure about half of the patients with VT and reduce the number of episodes for another 30 percent of patients.
Percutaneous left atrial appendage (LAA) ligation, pioneered at UCSF Medical Center, reduces the risks of thrombus formation with the LAA, which is often the source of stroke-causing clots associated with atrial fibrillation.
Advances in and experience with the treatment of complex aortic aneurysms, especially the use of novel endovascular devices and hybrid procedures, allow physicians to offer the best possible treatment to each patient and to broaden the list of viable candidates.
See information on upcoming continuing medical education courses.
To make a referral or get information about the UCSF Heart and Vascular Center, call (888) HVC-8911 or (888) 482-9911.
The UCSF Transfer Center is open 24 hours daily to coordinate the transfer of your patients to UCSF Medical Center from hospitals throughout the region.
Phone: (415) 353-9166
Fax: (415) 353-9172